Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Improvement Project Around Staffs' Influenza Vaccine Uptake

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03637036
Recruitment Status : Completed
First Posted : August 17, 2018
Last Update Posted : January 23, 2019
Sponsor:
Collaborator:
University Hospital Birmingham
Information provided by (Responsible Party):
Professor Richard Lilford, University of Warwick

Brief Summary:
To reach seasonal vaccination against influenza targets, University Hospitals Birmingham (UHB) already invites staff to take up the vaccination, and every November reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent different reminders, and the investigators will compare the proportion of staff that go on to vaccinate after receiving each reminder.

Condition or disease Intervention/treatment Phase
Influenza Vaccination Other: Communication intervention Not Applicable

Detailed Description:

Seasonal vaccination against influenza is recommended for NHS staff. , To increase vaccination rates, NHS England put forth a Commissioning for Quality and Innovation goal for the 2018/2019 season of 75%. University Hospitals Birmingham NHS Foundation Trust (UHB) wants its vaccination rate to surpass this target. Since staff get infected outside of the hospital and from patients staff vaccination does not provide significant 'herd immunity'

To reach past targets, every September UHB already invites staff to take up the vaccination, and regularly reminds staff that have not yet vaccinated to do so. The current protocol describes a randomized controlled trial (RCT) in which staff will be sent a different letter when first invited to receive vaccination, and we will compare the proportion of staff that go on to vaccinate after receiving each type of letter..

To conduct the RCT the research team will design four letter styles. One factor will emphasize an authority figure inviting staff to vaccinate (the Chief Executive, who is also a doctor). The other factor will emphasize a competitive social norm describing vaccination rates in peer hospitals, including Addenbrooke's, Cambridge University Hospitals (which has exemplary rates) see appendix A and across American hospitals (which also have high rates). Letters will be sent to staff in the first week in October by UHB's communications team and they will be disseminated in a randomized fashion.

The UoW's role in this study is to advise the study's design and write-up the project for publication. UHB will approve the reminders, send the reminders, retrieve the data, and analyse the data. No individual-level data will be transferred across organizations. All individual-level data will be managed by authorized UHB employees, e.g., a UHB statistician will randomize staff to receive different reminders and analyze the data, and UHB's communication team to disseminate the reminders.


Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 8438 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Masking Description: Participants receive one of four types of communications inviting them to take up the influenza vaccination in a randomized fashion. Participants will not be explicitly told that alternative versions of the communications are being sent.
Primary Purpose: Health Services Research
Official Title: An Improvement Project to Evaluate the Effectiveness of Different Reminders Designed to Increase the University Hospitals Birmingham NHS Foundation Trust's Staff Uptake of the Seasonal Influenza Vaccine
Actual Study Start Date : September 24, 2018
Actual Primary Completion Date : January 4, 2019
Actual Study Completion Date : January 4, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Flu Flu Shot

Arm Intervention/treatment
Control Condition
A general communication intervention will occur inviting staff to take up the influenza vaccination, without a specific authority or social norm designated.
Other: Communication intervention
The intervention is a communication inviting staff to take up the influenza vaccination. Different versions of the communication are created, and the investigators will compare uptake rates between staff that received different letters.

Authority Condition
A communication intervention will occur inviting staff to take up the influenza vaccination with a specific authority but not a social norm designated.
Other: Communication intervention
The intervention is a communication inviting staff to take up the influenza vaccination. Different versions of the communication are created, and the investigators will compare uptake rates between staff that received different letters.

Norms Condition
A communication intervention will occur inviting staff to take up the influenza vaccination with a social norm but not a specific authority designated.
Other: Communication intervention
The intervention is a communication inviting staff to take up the influenza vaccination. Different versions of the communication are created, and the investigators will compare uptake rates between staff that received different letters.

Authority + Norms Condition
A communication intervention will occur inviting staff to take up the influenza vaccination with a specific authority and a social norm designated.
Other: Communication intervention
The intervention is a communication inviting staff to take up the influenza vaccination. Different versions of the communication are created, and the investigators will compare uptake rates between staff that received different letters.




Primary Outcome Measures :
  1. Vaccination uptake [ Time Frame: 3 months ]
    Whether participants vaccinated (Yes, No)


Secondary Outcome Measures :
  1. Vaccination uptake date [ Time Frame: 3 months ]
    The date participants received vaccination (DD-MM-YYYY or blank if not vaccinated)

  2. Vaccination uptake reflusal [ Time Frame: 3 months ]
    Whether participants formally indicated refusal to vaccinate (Yes, No)

  3. Vaccination uptake alternative location [ Time Frame: 3 ]
    Whether participants formally indicated being vaccinated at another location (Yes, No)


Other Outcome Measures:
  1. Group number [ Time Frame: 3 months ]
    This data describes what communication participants received

  2. Worksite [ Time Frame: 3 months ]
    This data describes what location within the organization participants work

  3. Job Role [ Time Frame: 3 months ]
    This data describes participants' job roles

  4. Gender [ Time Frame: 3 months ]
    This data describes participants' gender



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All UHB staff eligible for the seasonal influenza vaccination are eligible for this study. (no patients are included)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03637036


Locations
Layout table for location information
United Kingdom
University Hospitals Birmingham NHS Foundation Trust (UHB)
Birmingham, United Kingdom, B15 2GW
Sponsors and Collaborators
University of Warwick
University Hospital Birmingham
Investigators
Layout table for investigator information
Principal Investigator: Richard J Lilford University of Warwick
  Study Documents (Full-Text)

Documents provided by Professor Richard Lilford, University of Warwick:

Layout table for additonal information
Responsible Party: Professor Richard Lilford, Professor of Public Health, University of Warwick
ClinicalTrials.gov Identifier: NCT03637036     History of Changes
Other Study ID Numbers: RRK6479
First Posted: August 17, 2018    Key Record Dates
Last Update Posted: January 23, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: Individual data will not be shared.

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Influenza, Human
Orthomyxoviridae Infections
RNA Virus Infections
Virus Diseases
Respiratory Tract Infections
Respiratory Tract Diseases